Johnson & Johnson (JNJ) stock analysis

In our weekly check, Johnson & Johnson is graded B (A to F). Of 25 checks on debt, profit, cash flow and trend: 19 pass, warnings: 4, red flags: 2.

About Johnson & Johnson

Johnson & Johnson is a Healthcare company (Drug Manufacturers - General) based in the United States, listed on NYSE as JNJ.

What our checks show for JNJ

Red flags

Warning signs

Strengths

Next earnings report: 2027-01-26

Similar companies

ABBV · MRK · LLY · NVS · AZN · AMGN

Questions

What grade does Johnson & Johnson (JNJ) have?

In our weekly check, Johnson & Johnson is graded B (A to F). Of 25 checks on debt, profit, cash flow and trend: 19 pass, warnings: 4, red flags: 2. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of JNJ stock?

This week's biggest flags for Johnson & Johnson: Margins falling, Slow recovery after falls, Gross margin falling. In total 6 of 25 checks show a warning or a red flag.

What does Johnson & Johnson do?

Johnson & Johnson is a Healthcare company (Drug Manufacturers - General) based in the United States, listed on NYSE as JNJ.

When does Johnson & Johnson report earnings next?

The next earnings report is expected on 2027-01-26. We re-run the checks every week, so the grade can change after it.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-11-14

Open the full analysis